{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:29Z","timestamp":1790187089655,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA082710"],"award-info":[{"award-number":["P01 CA082710"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diagnostic follow-up of women with an abnormal Pap test is necessary to resolve the risk developing cervical cancer. The purpose of this study is to describe patient characteristics associated with timely receipt of a diagnostic colposcopy after an abnormal Pap test among Hispanic women in El Paso, a Texas-Mexico border city.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective chart review of Hispanic patients seen at an academic colposcopy clinic following an abnormal Pap test. An optimal diagnostic interval to colposcopy was based on a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) quality indicator and was defined as receipt of colposcopy within 90\u00a0days or less from the date of an abnormal Pap test. Risk ratios (RR) were calculated by building a generalized linear model fit using a Poisson distribution, log link, and robust variance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 177 of the 270 women (65.6%) received follow-up within an optimal diagnostic interval. After adjusting for other variables in the model, women who were 30\u00a0years of age or older were 32% more likely to have an optimal interval than younger women (adjusted RR\u2009=\u20091.32, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). High school graduates were less likely than more educated women to have an optimal interval (adjusted RR\u2009=\u20090.68, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Participation in the NBCCEDP was not associated with receipt of follow-up within an optimal diagnostic interval.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared with women with greater educational attainment, high school graduates were less likely to receive follow-up within an optimal diagnostic interval, as were younger (&lt;\u200930\u00a0years) women compared with older women. Participation in the NBCCEDP was not associated with receipt of care within an optimal diagnostic interval.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-020-01161-9","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T21:03:31Z","timestamp":1609967011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Predictors of timely diagnostic follow-up after an abnormal Pap test among Hispanic women seeking care in El Paso, Texas"],"prefix":"10.1186","volume":"21","author":[{"given":"Thelma","family":"Carrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R.","family":"Montealegre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina G.","family":"Bracamontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Follen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-5702","authenticated-orcid":false,"given":"Zuber D.","family":"Mulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"7","key":"1161_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10552-009-9317-z","volume":"20","author":"J Barnholtz-Sloan","year":"2009","unstructured":"Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Cause Control. 2009;20(7):1129\u201338.","journal-title":"Cancer Cause Control"},{"key":"1161_CR2","volume-title":"SEER cancer statistics review, 1975\u20132012","author":"NA Howlader","year":"2015","unstructured":"Howlader NA, Krapcho M, Garshell J, et al. SEER cancer statistics review, 1975\u20132012. Bethesda, MD: National Cancer Institute; 2015."},{"issue":"10 Suppl","key":"1161_CR3","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1002\/cncr.23756","volume":"113","author":"M Watson","year":"2008","unstructured":"Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998\u20132003. Cancer. 2008;113(10 Suppl):2855\u201364.","journal-title":"Cancer"},{"issue":"47","key":"1161_CR4","first-page":"1067","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","unstructured":"Centers for Disease Control and Prevention (CDC). Invasive cervical cancer among Hispanic and non-Hispanic women\u2014United States, 1992\u20131999. Morbid Mortal Wkly Rep. 2002;51(47):1067\u201370.","journal-title":"Morbid Mortal Wkly Rep"},{"key":"1161_CR5","unstructured":"U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999\u20132013 Incidence and mortality web-based report. Atlata, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2015."},{"key":"1161_CR6","unstructured":"Risser DR, Mokry B, Bowcock C, Miller EA, Williams MA, Magid R, Garcia R. Cervical Cancer in Texas, 2010. Austin, TX: Texas Cancer Registry, Texas Department of State Health Services; Cancer Prevention Research Institute of Texas, November 2010."},{"key":"1161_CR7","unstructured":"Texas Department of State Health Services. Texas behavioral risk factor surveillance system. Austing, TX. 2014. http:\/\/healthdata.dshs.texas.gov. Accessed 20 Oct 2016."},{"issue":"6","key":"1161_CR8","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1097\/01.AOG.0000159549.56601.75","volume":"105","author":"VB Benard","year":"2005","unstructured":"Benard VB, Lawson HW, Eheman CR, Anderson C, Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obst Gynecol. 2005;105(6):1323\u20138.","journal-title":"Obst Gynecol"},{"issue":"10","key":"1161_CR9","first-page":"1015","volume":"10","author":"LP Engelstad","year":"2001","unstructured":"Engelstad LP, Stewart SL, Nguyen BH, et al. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol Biomarkers Prev. 2001;10(10):1015\u201320.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1161_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5858\/2000-124-0665-FUOAGC","volume":"124","author":"BAND Jones","year":"2000","unstructured":"Jones BAND. Follow-up of abnormal gynecologic cytology: a College of American Pathologists Q-Probes study of 16132 cases from 306 laboratories. Arch Pathol Lab Med. 2000;124:665\u201371.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"1161_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/jnci\/dji115","volume":"97","author":"WA Leyden","year":"2005","unstructured":"Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675\u201383.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"1161_CR12","first-page":"825","volume":"95","author":"NB Peterson","year":"2003","unstructured":"Peterson NB, Han J, Freund KM. Inadequate follow-up for abnormal Pap smears in an urban population. J Natl Med Assoc. 2003;95(9):825\u201332.","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"1161_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/1751-486X.12148","volume":"18","author":"UA Pritham","year":"2014","unstructured":"Pritham UA, Brigdon A, Jones M. Understanding factors related to women\u2019s adherence to colposcopy. Nurs Womens Health. 2014;18(5):402\u201312.","journal-title":"Nurs Womens Health"},{"issue":"3","key":"1161_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.21139","volume":"62","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam S, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. CA Canc J Clin. 2012;62(3):147\u201372.","journal-title":"CA Canc J Clin"},{"issue":"2","key":"1161_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ygyno.2008.11.002","volume":"112","author":"KT Ashing-Giwa","year":"2009","unstructured":"Ashing-Giwa KT, Tejero JS, Kim J, Padilla GV, Kagawa-Singer M, Tucker MB, et al. Cervical cancer survivorship in a population based sample. Gynecol Oncol. 2009;112(2):358\u201364.","journal-title":"Gynecol Oncol"},{"issue":"17","key":"1161_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/jnci\/djh255","volume":"96","author":"KR Yabroff","year":"2004","unstructured":"Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322\u201330.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"1161_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/0002-9378(91)90304-A","volume":"165","author":"C Lerman","year":"1991","unstructured":"Lerman C, Miller SM, Scarborough R, Hanjani P, Nolte S, Smith D. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obst Gynecol. 1991;165(3):658\u201362.","journal-title":"Am J Obst Gynecol"},{"issue":"1","key":"1161_CR18","first-page":"17","volume":"6","author":"SE Brooks","year":"2002","unstructured":"Brooks SE, Gordon NJ, Keller SJ, Thomas SK, Chen TT, Moses G. Association of knowledge, anxiety, and fear with adherence to follow up for colposcopy. J Lower Genital Tract Dis. 2002;6(1):17\u201322.","journal-title":"J Lower Genital Tract Dis"},{"issue":"016","key":"1161_CR19","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/cncr.28820","volume":"120","author":"NC Lee","year":"2014","unstructured":"Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, et al. Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning. Cancer. 2014;120(016):2540\u20138.","journal-title":"Cancer"},{"issue":"7","key":"1161_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1089\/jwh.2011.3224","volume":"21","author":"VB Benard","year":"2012","unstructured":"Benard VB, Howe W, Royalty J, Helsel W, Kammerer W, Richardson LC. Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health. 2012;21(7):776\u201382.","journal-title":"J Womens Health"},{"issue":"7","key":"1161_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10552-010-9536-3","volume":"21","author":"FK Tangka","year":"2010","unstructured":"Tangka FK, O\u2019Hara B, Gardner JG, Turner J, Royalty J, Shaw K, et al. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004\u20132006. Cancer Cause Control. 2010;21(7):1081\u201390.","journal-title":"Cancer Cause Control"},{"issue":"10","key":"1161_CR22","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1158\/1055-9965.EPI-08-0137","volume":"17","author":"M Cardenas-Turanzas","year":"2008","unstructured":"Cardenas-Turanzas M, Nogueras-Gonzalez GM, Scheurer ME, Adler-Storthz K, Benedet JL, Beck JR, et al. The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2865\u201371.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1 Suppl","key":"1161_CR23","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.genm.2011.08.002","volume":"9","author":"TPH Buys","year":"2012","unstructured":"Buys TPH, Cantor SB, Guillaud M, Adler-Storthz K, Cox DD, Okolo C, et al. Optical technologies and molecular imaging for cervical neoplasia: a program project update. Gend Med. 2012;9(1 Suppl):S7\u201324.","journal-title":"Gend Med"},{"issue":"2","key":"1161_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/07399863870092005","volume":"9","author":"G Mar\u00edn","year":"1987","unstructured":"Mar\u00edn G, Sabogal F, VanOss MB, Otero-Sabogal R, P\u00e9rez-Stable EJ. Development of a short acculturation scale for Hispanics. Hisp J Behav Sci. 1987;9(2):183\u2013205.","journal-title":"Hisp J Behav Sci"},{"issue":"7","key":"1161_CR25","doi-asserted-by":"publisher","first-page":"e68064","DOI":"10.1371\/journal.pone.0068064","volume":"8","author":"E Ert","year":"2013","unstructured":"Ert E, Yechiam E, Arshavsky O. Smokers\u2019 decision making: more than mere risk taking. PLoS ONE. 2013;8(7):e68064.","journal-title":"PLoS ONE"},{"issue":"1","key":"1161_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/archpedi.1997.02170380070011","volume":"151","author":"LG Escobedo","year":"1997","unstructured":"Escobedo LG, Reddy M, DuRant RH. Relationship between cigarette smoking and health risk and problem behaviors among US adolescents. Arch Pediatr Adoles Med. 1997;151(1):66\u201371.","journal-title":"Arch Pediatr Adoles Med"},{"issue":"3","key":"1161_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/aje\/kwi188","volume":"162","author":"D Spiegelman","year":"2005","unstructured":"Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199\u2013200.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"1161_CR28","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1055-9965.EPI-12-0535","volume":"21","author":"TW Markossian","year":"2012","unstructured":"Markossian TW, Darnell JS, Calhoun EA. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomarkers Prev. 2012;21(10):1691\u2013700.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1161_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10903-012-9754-8","volume":"16","author":"JR Montealegre","year":"2014","unstructured":"Montealegre JR, Selwyn BJ. Healthcare coverage and use among undocumented Central American immigrant women in Houston, Texas. J Immigr Minor Health. 2014;16(2):204\u201310.","journal-title":"J Immigr Minor Health"},{"issue":"7","key":"1161_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1089\/152460902760360586","volume":"11","author":"K Ell","year":"2002","unstructured":"Ell K, Vourlekis B, Muderspach L, Nissly J, Padgett D, Pineda D, et al. Abnormal cervical screen follow-up among low-income Latinas: project SAFe. J Womens Health Gend Based Med. 2002;11(7):639\u201351.","journal-title":"J Womens Health Gend Based Med"},{"key":"1161_CR31","first-page":"1","volume":"29","author":"RA Cohen","year":"2010","unstructured":"Cohen RA, Bloom B. Access to and utilization of medical care for young adults ages 20\u201329 years: United States, 2008. NCHS Data Brief. 2010;29:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"4","key":"1161_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/2150131914529307","volume":"5","author":"SK Hui","year":"2014","unstructured":"Hui SK, Miller SM, Wen KY, Fang Z, Li T, Buzaglo J, et al. Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women. J Prim Care Community Health. 2014;5(4):234\u201341.","journal-title":"J Prim Care Community Health"},{"issue":"2","key":"1161_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/gyn.1986.2.83","volume":"2","author":"JMG Beresford","year":"2009","unstructured":"Beresford JMG. The Emotional Impact of Abnormal Pap Smears on Patients Referred for Colposcopy. J Gynecol Surg. 2009;2(2):83\u20137.","journal-title":"J Gynecol Surg"},{"issue":"3","key":"1161_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0090-8258(89)90170-4","volume":"34","author":"TW McDonald","year":"1989","unstructured":"McDonald TW, Neutens JJ, Fischer LM, Jessee D. Impact of cervical intraepithelial neoplasia diagnosis and treatment on self-esteem and body image. Gynecol Oncol. 1989;34(3):345\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1161_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejogrb.2012.08.001","volume":"165","author":"L Sharp","year":"2012","unstructured":"Sharp L, Cotton S, Thornton A, Gray N, Cruickshank M, Whynes D, et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. Eur J Obst Gynecol Rep Biol. 2012;165(2):318\u201325.","journal-title":"Eur J Obst Gynecol Rep Biol"},{"issue":"5","key":"1161_CR36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/1090198115580975","volume":"42","author":"AF Abra\u00eddo-Lanza","year":"2015","unstructured":"Abra\u00eddo-Lanza AF, Martins MC, Shelton RC, Fl\u00f3rez KR. Breast cancer screening among Dominican Latinas: a closer look at fatalism and other social and cultural factors. Health Educ Behav. 2015;42(5):633\u201341.","journal-title":"Health Educ Behav"},{"issue":"4","key":"1161_CR37","first-page":"1032","volume":"2","author":"R Fairchild","year":"2015","unstructured":"Fairchild R. Fatalism and health behaviors: Exploring the context for clinician-patient interactions. Ann Nurs Pract. 2015;2(4):1032.","journal-title":"Ann Nurs Pract"},{"key":"1161_CR38","volume-title":"Current population reports, P60\u2013260, health insurance coverage in the United States: 2016","author":"JC Barnett","year":"2017","unstructured":"Barnett JC, Berchick ER. Current population reports, P60\u2013260, health insurance coverage in the United States: 2016. Washington, DC: U.S. Government Printing Office; 2017."},{"issue":"1","key":"1161_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12905-019-0736-z","volume":"19","author":"L Marlow","year":"2019","unstructured":"Marlow L, McBride E, Varnes L, Waller J. Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England. BMC Women\u2019s Health. 2019;19(1):38.","journal-title":"BMC Women\u2019s Health"}],"updated-by":[{"DOI":"10.1186\/s12905-021-01186-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000}}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-01161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-020-01161-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-020-01161-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T07:06:11Z","timestamp":1612249571000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-020-01161-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1186\/s12905-020-01161-9","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12905-021-01186-8","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Administrative permissions were not required to access and use our study data. This project was a quality improvement investigation which used a de-identified dataset that was derived from a study that was previously approved by the Institutional Review Board (IRB) for the Protection of Human Subjects of the Texas Tech University Health Sciences Center El Paso. An application was submitted to our IRB on 16 December 2020. On 18 December 2020 our IRB issued a letter stating that they do not typically review quality improvement projects. Additionally, our IRB does not consider the analysis of a de-identified dataset to meet the definition of human subjects research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}